DrugPatentWatch Database Preview
AKYNZEO Drug Profile
When do Akynzeo patents expire, and what generic alternatives are available?
Akynzeo is a drug marketed by Helsinn Hlthcare and is included in two NDAs. There are twelve patents protecting this drug.
This drug has two hundred and nine patent family members in sixty-seven countries.
The generic ingredient in AKYNZEO is fosnetupitant chloride hydrochloride; palonosetron hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the fosnetupitant chloride hydrochloride; palonosetron hydrochloride profile page.
Summary for AKYNZEO
| International Patents: | 209 |
| US Patents: | 12 |
| Applicants: | 1 |
| NDAs: | 2 |
| Suppliers / Packagers: | 1 |
| Clinical Trials: | 4 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for AKYNZEO |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for AKYNZEO |
| Prior Art and Litigation Support | Order Prior Art and Litigation support for AKYNZEO |
| DailyMed Link: | AKYNZEO at DailyMed |
Generic Entry Opportunity Date for AKYNZEO
Generic Entry Dates for AKYNZEO*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
CAPSULE;ORAL |
Generic Entry Dates for AKYNZEO*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
POWDER;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for AKYNZEO
US Patents and Regulatory Information for AKYNZEO
Expired US Patents for AKYNZEO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for AKYNZEO
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Singapore | 11201402044X | ➤ Try a Free Trial |
| Iceland | 2116 | ➤ Try a Free Trial |
| Malaysia | 147451 | ➤ Try a Free Trial |
| Singapore | 91856 | ➤ Try a Free Trial |
| Philippines | 12014501199 | ➤ Try a Free Trial |
| Israel | 134654 | ➤ Try a Free Trial |
| Morocco | 33810 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for AKYNZEO
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1035115 | C01035115/01 | Switzerland | ➤ Try a Free Trial | PRODUCT NAME: NETUPITANT; REGISTRATION NO/DATE: SWISSMEDIC 65499 06.11.2015 |
| 1035115 | C300758 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: NETUPITANT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH; REGISTRATION NO/DATE: EU/1/15/1001 20150527 |
| 1035115 | 300758 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: NETUPITANT, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/15/1001 20150527 |
| 1035115 | 92745 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: NETUPITANT/PALONOSETRON ET LEURS DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (AKYNZEO); FIRST REGISTRATION: 20150527 |
| 1035115 | 43/2015 | Austria | ➤ Try a Free Trial | PRODUCT NAME: NETUPITANT; REGISTRATION NO/DATE: EU/1/15/1001 20150527 |
| 1035115 | 1590040-0 | Sweden | ➤ Try a Free Trial | PRODUCT NAME: NETUPITANT; REG. NO/DATE: EU/1/15/1001 20150529 |
| 1035115 | CA 2015 00044 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: NETUPITANT; REG. NO/DATE: EU/1/15/1001 20150527 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
